Related content

Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients

By Ohnishi Yasuyuki   Tsutsumi Akito   Matsumoto Isao   Goto Daisuke   Ito Satoshi   Kuwana Masataka   Uemura Yasushi   Nishimura Yasuharu   Sumida Takayuki  

Modern Rheumatology, Vol. 16, Iss. 4, 2006-08 ,pp. : 226-228

Springer Publishing Company

Access to resources Recommend Favorite

Immunosenescence, autoimmunity, and rheumatoid arthritis

By Weyand C.M.   Fulbright J.W.   Goronzy J.J.  

Experimental Gerontology, Vol. 38, Iss. 8, 2003-08 ,pp. : 833-841

Elsevier

Access to resources Recommend Favorite

Serological investigation of IgG levels and subclasses in rheumatoid arthritis patients following ingestion of bovine type II collagen: results of a double blind, randomised controlled trial

By Farboud Amir   Choy Ernest  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 193-199

Springer Publishing Company

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

The alpha 2 type IX collagen gene tryptophan polymorphism is not associated with rheumatoid arthritis in the Japanese population

By Takata Yoichiro   Matsui Yoshito   Hamada Daisuke   Goto Tomohiro   Kubo Takahiro   Egawa Hiroshi   Nakano Shunji   Shinomiya Fumio   Inoue Hiroshi   Itakura Mitsuo   Yasui Natsuo  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 491-494

Springer Publishing Company

Access to resources Recommend Favorite